A real-world study of Afatinib plus ramucirumab in treatment-naive, EGFR-mutated, non-small cell lung cancer. Huang CY, Huang HL, Lan CC, Huang YC, et al. BMC Cancer 2023;23:413.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang CY, Huang HL, Lan CC, Huang YC, et al. A real-world study of Afatinib plus ramucirumab in treatment-naive, EGFR-mutated, non-small cell lung cancer. BMC Cancer 2023;23:413.
PMID: 37158884